Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2012 1
2013 1
2014 1
2015 1
2019 2
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cheng gang ying (1 results)?
Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M, Qin C, Tao L, Cheng G, Li J, Lv F, Yang N, Xing Z, Chu X, Han X, Huo M, Yin L. Yang M, et al. Among authors: cheng g. Biomaterials. 2023 Oct;301:122253. doi: 10.1016/j.biomaterials.2023.122253. Epub 2023 Jul 25. Biomaterials. 2023. PMID: 37536040
Effectively Increasing Pt Utilization Efficiency of the Membrane Electrode Assembly in Proton Exchange Membrane Fuel Cells through Multiparameter Optimization Guided by Machine Learning.
Ding R, Yin W, Cheng G, Chen Y, Wang J, Wang X, Han M, Zhang T, Cao Y, Zhao H, Wang S, Li J, Liu J. Ding R, et al. Among authors: cheng g. ACS Appl Mater Interfaces. 2022 Feb 16;14(6):8010-8024. doi: 10.1021/acsami.1c23221. Epub 2022 Feb 2. ACS Appl Mater Interfaces. 2022. PMID: 35107272
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.
Zhou C, Wu YL, Chen G, Liu X, Zhu Y, Lu S, Feng J, He J, Han B, Wang J, Jiang G, Hu C, Zhang H, Cheng G, Song X, Lu Y, Pan H, Zheng W, Yin AY. Zhou C, et al. Among authors: cheng g. J Clin Oncol. 2015 Jul 1;33(19):2197-204. doi: 10.1200/JCO.2014.59.4424. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014294 Clinical Trial.
11 results